Sera Prognostics (SERA) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
4 Jun, 2026Opening remarks and agenda
Meeting called to order at 9:00 A.M. Mountain Time and held virtually to improve shareholder access.
Agenda and rules of conduct were made available to all participants, with opportunities for questions on proposals.
Board and executive committee updates
Current directors and management introduced, including nominees for re-election and key executives.
Biographies of director nominees provided in the proxy statement.
Corporate governance
Quorum established with 67.48% of outstanding voting stock represented.
Meeting held pursuant to notice mailed to stockholders of record.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Sera Prognostics
- PreTRM enables early, accurate preterm birth risk prediction, reducing NICU admissions and costs.SERA
Corporate presentation - Illinois Medicaid coverage, new partnerships, and clinical data drove revenue growth despite net loss.SERA
Q2 2026 - Breakthrough biomarker test and preventive bundle cut NICU admissions and costs, driving adoption.SERA
TD Cowen 45th Annual Healthcare Conference - Commercial focus accelerates after PRIME results, with reimbursement and awareness as top priorities.SERA
Jefferies Global Healthcare Conference 2026 - Director nominee resignation leads to a reduced board; proxy votes for him will not be counted.SERA
Proxy filing - Strong trial results drive rapid state and payer engagement for preterm birth screening.SERA
TD Cowen 46th Annual Health Care Conference - PreTRM enables early, accurate preterm birth risk prediction, improving outcomes and reducing costs.SERA
Corporate presentation - Net loss of $8.4M on $14,000 revenue, with cash runway extended through 2029.SERA
Q1 2026 - Q1 2025 revenue grew to $38,000; cash rose to $114.2M amid Medicaid-focused PreTRM expansion.SERA
Q1 2025